Aleafia Health Inc. operates as an integrated cannabis health and wellness company.
High growth potential and fair value.
Share Price & News
How has Aleafia Health's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ALEF's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: ALEF underperformed the Canadian Healthcare industry which returned -41.2% over the past year.
Return vs Market: ALEF underperformed the Canadian Market which returned -26% over the past year.
Price Volatility Vs. Market
How volatile is Aleafia Health's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall StSome Aleafia Health (TSE:ALEF) Shareholders Have Taken A Painful 80% Share Price Drop
2 months ago | Simply Wall StIs Aleafia Health (TSE:ALEF) Using Debt In A Risky Way?
4 months ago | Simply Wall StSuch Is Life: How Aleafia Health (TSE:ALEF) Shareholders Saw Their Shares Drop 68%
Is Aleafia Health undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: ALEF (CA$0.41) is trading below our estimate of fair value (CA$3.99)
Significantly Below Fair Value: ALEF is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: ALEF is unprofitable, so we can't compare its PE Ratio to the Healthcare industry average.
PE vs Market: ALEF is unprofitable, so we can't compare its PE Ratio to the Canadian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate ALEF's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: ALEF is good value based on its PB Ratio (0.3x) compared to the CA Healthcare industry average (1.8x).
How is Aleafia Health forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ALEF is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.4%).
Earnings vs Market: ALEF is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ALEF's is expected to become profitable in the next 3 years.
Revenue vs Market: ALEF's revenue (32.2% per year) is forecast to grow faster than the Canadian market (3.9% per year).
High Growth Revenue: ALEF's revenue (32.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ALEF's Return on Equity is forecast to be low in 3 years time (6.1%).
How has Aleafia Health performed over the past 5 years?
Last years earnings growth
Earnings and Revenue History
Quality Earnings: ALEF is currently unprofitable.
Growing Profit Margin: ALEF is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if ALEF's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare ALEF's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ALEF is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (2.7%).
Return on Equity
High ROE: ALEF has a negative Return on Equity (-10.3%), as it is currently unprofitable.
How is Aleafia Health's financial position?
Financial Position Analysis
Short Term Liabilities: ALEF's short term assets (CA$117.6M) exceed its short term liabilities (CA$20.7M).
Long Term Liabilities: ALEF's short term assets (CA$117.6M) exceed its long term liabilities (CA$57.1M).
Debt to Equity History and Analysis
Debt Level: ALEF's debt to equity ratio (13.3%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if ALEF's debt to equity ratio has reduced over the past 5 years.
Inventory Level: ALEF has a high level of physical assets or inventory.
Debt Coverage by Assets: ALEF's debt is covered by short term assets (assets are 2.3x debt).
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ALEF has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ALEF has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is Aleafia Health's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate ALEF's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate ALEF's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ALEF's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ALEF's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ALEF's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Geoffrey Benic, also known as Geoff, has been Chief Executive Officer of Aleafia Health Inc since June 28, 2018. Previously, Mr. Benic served as the Regional Director of United Parcel Service Canada Lt ...
CEO Compensation Analysis
Compensation vs Market: Geoff's total compensation ($USD136.27K) is about average for companies of similar size in the Canadian market ($USD159.52K).
Compensation vs Earnings: Insufficient data to compare Geoff's compensation with company performance.
|Chief Executive Officer||1.75yrs||CA$191.78k||no data|
|CFO & Corporate Secretary||1.58yrs||CA$170.94k||no data|
|Chief Medical Officer||1.92yrs||CA$111.22k||0.062% CA$69.7k|
|Chief Operating Officer||1.58yrs||no data||no data|
|Chief Marketing & Technology Officer||1.58yrs||no data||no data|
|Vice President of Investor Relations & Public Affairs||no data||no data||0.0056% CA$6.3k|
|General Counsel||1yr||no data||no data|
|Vice President of Human Resources||1.17yrs||no data||no data|
|President of Clinic Operations||1yr||no data||no data|
|Head of FoliEdge Academy||0.92yr||no data||no data|
Experienced Management: ALEF's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
|Independent Director||1yr||no data||no data|
|Lead Independent Director||0.42yr||no data||no data|
|Independent Director||1yr||no data||0.0030% CA$3.4k|
|Chairman of the Board||2yrs||CA$847.29k||1.62% CA$1.8m|
|Independent Director||1.83yrs||no data||0.18% CA$206.5k|
|Independent Director||1.92yrs||no data||no data|
Experienced Board: ALEF's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: ALEF insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 84%.
Aleafia Health Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Aleafia Health Inc.
- Ticker: ALEF
- Exchange: TSX
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: CA$112.547m
- Shares outstanding: 277.89m
- Website: https://www.aleafiahealth.com
Number of Employees
- Aleafia Health Inc.
- 8810 Jane Street
- 2nd Floor
- L4K 2M9
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|ALEF||TSX (The Toronto Stock Exchange)||Yes||Common Shares||CA||CAD||Mar 2018|
|ALEA.F||OTCPK (Pink Sheets LLC)||Yes||Common Shares||US||USD||Mar 2018|
|ARAH||DB (Deutsche Boerse AG)||Yes||Common Shares||DE||EUR||Mar 2018|
Aleafia Health Inc. operates as an integrated cannabis health and wellness company. It produces a portfolio of products, including dried flower and pre-rolls, as well as oil drops and capsules, and oral sprays. The company offers its products under the Emblem and Symbl brands. It also operates a network of 25 medical cannabis clinics; and education centers. Aleafia Health Inc. is headquartered in Concord, Canada.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/03/30 04:43|
|End of Day Share Price||2020/03/27 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.